NEOGENOMICS INC — Director's Dealing 2025

Jun 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-06-01

Reporting Person: Gunn Neil (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-01	Common Stock	M	12254	—	Acquired	28100.31	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-01	Restricted Stock Unit	$0	M	12254	Disposed		Common Stock (12254)	Direct
2025-06-01	Stock Option (Right to Buy)	$7.28	A	16107	Acquired	2035-06-01	Common Stock (16107)	Direct
2025-06-01	Restricted Stock Unit	$0	A	23077	Acquired		Common Stock (23077)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$14.82	2033-08-10	Common Stock (8353)	8353	Direct
Stock Option (Right to Buy)	$13.71	2034-06-01	Common Stock (8672)	8672	Direct

Footnotes

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Once vested, the shares of common stock are not subject to expiration.